Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

UNITED THERAPEUTICS (UTHR) EPS (Basic): 2009-2024

Historic EPS (Basic) for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $26.44.

  • UNITED THERAPEUTICS's EPS (Basic) rose 11.54% to $7.73 in Q3 2025 from the same period last year, while for Sep 2025 it was $28.48, marking a year-over-year increase of 17.15%. This contributed to the annual value of $26.44 for FY2024, which is 25.67% up from last year.
  • Per UNITED THERAPEUTICS's latest filing, its EPS (Basic) stood at $26.44 for FY2024, which was up 25.67% from $21.04 recorded in FY2023.
  • Over the past 5 years, UNITED THERAPEUTICS's EPS (Basic) peaked at $26.44 during FY2024, and registered a low of $10.60 during FY2021.
  • For the 3-year period, UNITED THERAPEUTICS's EPS (Basic) averaged around $21.15, with its median value being $21.04 (2023).
  • Its EPS (Basic) has fluctuated over the past 5 years, first soared by 587.45% in 2020, then decreased by 9.01% in 2021.
  • Yearly analysis of 5 years shows UNITED THERAPEUTICS's EPS (Basic) stood at $11.65 in 2020, then dropped by 9.01% to $10.60 in 2021, then skyrocketed by 50.75% to $15.98 in 2022, then soared by 31.66% to $21.04 in 2023, then increased by 25.67% to $26.44 in 2024.